Recent Headlines
MoBiTec to Offer New Transcreener UDP2 TR-FRET Assay, Manufactured by BellBrook Labs
Just like the existing UDP2 FP assay, the TR-FRET assay provides sensitive detection of glycosyltransferases and other UDP-producing enzymes. The new Transcreener UDP2 TR-FRET Assay will better serve a growing need for robust, HTS-proven glycosyltransferase assays for drug discovery. - January 31, 2015 - MoBiTec GmbH
HiLyte™ Your Antibodies Using One Universal Reagent
AnaSpec is pleased to announce the release of a product line of recombinant Protein A, conjugated with HiLyte™ Fluor dyes or Biotin. This universal reagent can be used to detect antibodies from different species, such as human, rabbit, mouse, rat and others. Protein A is available as labeled... - January 30, 2015 - AnaSpec, EGT Group
Creative Bioarray Releases New Stem Cell Products
The US-based biotech company, Creative Bioarray has recently added hundred of kinds of stem cell products to its cell product repository. - January 24, 2015 - Creative Bioarray
VIRUN® NutraBIOsciences™ to Present at BEVERAGE INNOVATION 2015 on February 4th – Hear VIRUN talk Innovation from Water to Beer
VIRUN to present the latest-and-greatest at Beverage Innovation 2015, presented to you by FoodNavigator-USA and BeverageDaily. From cognitive waters containing Phosphatidylserine, DHA Omega-3 and weight-loss waters with high levels of Resveratrol and Curcumin that help regulate blood sugar, to heart-healthy waters containing 1000mg Phytosterols and 680mg EPA DHA Omega-3. From water to beer, raw material to finished product, VIRUN is your solutions-based resource. - January 20, 2015 - VIRUN
CHI Scientific Releases PrimaCell™ Protocols for Culturing More Than 300 Types of Primary Cells to Speed Biological Discoveries
Brings Standardized Methods to the Research Scientist, Greatly Reducing the Time Needed to Prepare and Culture Critical Tissue and Organ Cells. - January 16, 2015 - CHI Scientific Inc
Braasch Biotech Bolsters Intellectual Property with Patent Acceptance in the Philippines
Braasch Biotech LLC continues patent portfolio expansion with new issue in the Philippines. Novel technologies allow safe enhancement of livestock productivity by use of vaccination rather than exogenous pharmaceuticals. - January 15, 2015 - Braasch Biotech LLC
AveXis Closes Its Series C Financing Round with Deerfield Management and Roche Venture Fund
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced it has completed a $10 million financing round led by Deerfield Management and Roche Venture Fund. In... - January 08, 2015 - AveXis Inc.
Good News - Creative Biomart Newly Introduced Fucose-Free Protein Expression System
Creative Biomart, a world leading biotech company that specializes in providing advanced tolls for protein expression and purification, today has officially announced its release of novel service--Fucose-free Protein Expression System. According to its official speaker, this service is supported by... - January 07, 2015 - Creative Biomart
Creative Biomart Launches Special Promotion for Christmas and New Year
Creative Biomart, a world leading biotech company that provides recombinant proteins, enzymes and other quality products and services for customers all over the world, has announced today that they would launch a special promotion for Christmas and New year in this very day. According to its... - December 25, 2014 - Creative Biomart
Creative Biomart Newly Introduced Multiplex Protein Detect Assay
Creative Biomart, a world leading biotech company and the commitment of which is to improving people’s life by assisting scientists with their research, has announced today for its official release of Multiplex Protein Detect Assay Service. This release was said to provide better protein... - December 21, 2014 - Creative Biomart
Experimentica Ltd. Licenses Akimba Mouse Model for Diabetic Retinopathy from Lions Eye Institute, Australia
The Lions Eye Institute (LEI) and Experimentica Ltd., a global ophthalmic contract research organization (CRO) announced today that they have entered into an exclusive license agreement for the Akimba mouse model for diabetic retinopathy for contract research. The license agreement was facilitated by Bio-Link Australia, a life sciences commercialisation company. - December 20, 2014 - Experimentica Ltd
Ethan Jostad Foundation Gives Gift of Childhood Cancer Research
Non-Profit charity donates to pediatric cancer research for most difficult to treat childhood cancers. - December 20, 2014 - Ethan Jostad Foundation for Childhood Cancer
Brand New IHC Services Are Available Now at Creative Diagnostics
Creative Diagnostics has launched immunohistochemistry (IHC) and in situ hybridization (ISH) laboratory services for diagnostic and research purposes. - December 19, 2014 - Creative Diagnostics
Advanced Cancer Therapeutics’ PFK-158 Featured in CEO/CFO Magazine; Announces MD Anderson and UT Health Science Center San Antonio Added as Clinical Trial Sites
Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, has been featured in the December 15, 2014 issue of CEO/CFO Magazine in which ACT President and CEO Randall B. Riggs discusses PFK-158, a first-in-man/first-in-class inhibitor of PFKFB3, an enzyme that controls glycolysis and that is overexpressed in most hematological and solid tumors. - December 17, 2014 - Advanced Cancer Therapeutics
Paras Biopharmaceuticals Wins International Award
Paras Biopharmaceuticals wins the 2014 European Biopharmaceuticals Technology Innovation Leadership Award by Frost & Sullivan. - December 11, 2014 - Paras Biopharmaceuticals Finland Oy
EGFR Kit of AmoyDx, China, Supplier to MoBiTec, Germany, Ranks Top in 2014 Lung Cancer EMQN Report
The European Molecular Genetics Quality Network (EMQN) is an independent organization based in the UK that promotes improvement in the quality of genetic testing by ensuring that diagnostic molecular genetic laboratory test results are accurate, reliable, and comparable. - December 11, 2014 - MoBiTec GmbH
AveXis Announces Dosing of First Patient in Intermediate Cohort in Gene Transfer Trial
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), today announced that the first patient in the intermediate cohort in the Gene Transfer Clinical Trial for SMA Type 1 has... - December 10, 2014 - AveXis Inc.
AveXis Announces Launch of New Patient-Oriented Website Focused on Spinal Muscular Atrophy
AveXis, Inc., a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy (SMA), is pleased to announce the launch of the company’s brand new website specifically focused on SMA: www.smastudy.org. - December 04, 2014 - AveXis Inc.
MoBiTec, Germany to Offer Cryogenic Vials for Embryo Cryopreservation by Vitrification Manufactured by Sumitomo, Japan
In cryopreservation vitrification is a common method used to preserve egg cells and embryos. Of utmost importance is that the oocyte or embryo is stored in a vessel that allows appropriate temperature modulation. - December 03, 2014 - MoBiTec GmbH
MoBiTec, Germany, Offers a New Range of Monofluorinated Nucleosides Manufactured by Dextra, UK
Fluorine introduction can lead to a modification of the reactivity of functional groups, alter conformational stability and, in pharmaceuticals, enhance metabolic stability. Over 30% of leading blockbuster drugs contain at least one fluorine atom. - November 29, 2014 - MoBiTec GmbH
Advanced Cancer Therapeutics’ PFK-158 Selected as One of Informa and Kantar Health 2014 Top 10 Most Interesting Oncology Projects to Watch
Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, has been chosen by Informa and Kantar Health as one of the “2014 Top 10 Most Interesting Oncology Projects to Watch” for its compound, PFK-158. PFK-158 is a small... - November 27, 2014 - Advanced Cancer Therapeutics
8.5K in Los Angeles Raises $33,000 for PBTF
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on children with brain tumors, raised $33,000 in Los Angeles on Nov. 22. The 8.5K event at Griffith Park honored local children with brain tumors. These Stars were Adam, Bella, Brittney, Caitlyn, Cassie,... - November 27, 2014 - Pediatric Brain Tumor Foundation
Creative Bioarray Announces Product Promotiom for Magic™ Serum-Free Freezing Medium
Creative Bioarray announces its product promotion for Magic™ serum-free freezing medium towards the worldwide market. - November 26, 2014 - Creative Bioarray
Creative Biomart’s Most-Favored Services List is Available Now
Creative Biomart, a world leading biotech company that offers recombinant proteins, antibodies, antigens and a wide range of biotech services worldwide, today has released its most favored services list officially. It was said that this was done to make them have a better understanding of what... - November 22, 2014 - Creative Biomart
AveXis to Present at the 26th Annual Piper Jaffray Healthcare Conference
AveXis, a biotechnology company focused on using gene therapy to transform the lives of patients with severe genetic and orphan diseases like Spinal Muscular Atrophy, today announced that Mr. John Carbona, Chief Executive Officer, and Dr. Brian Kaspar will present at the 26th Annual Piper Jaffray... - November 21, 2014 - AveXis Inc.
Houston Runs to Help Kids with Brain Tumors
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on children with brain tumors, raised nearly $15,000 in Houston on Nov. 15. The 8.5K event at Discovery Green honored local children with brain tumors. These Stars were Mandy, Taylor, Tobin and... - November 20, 2014 - Pediatric Brain Tumor Foundation
Patent Awarded to AdvantaPure(R)’s AdvantaPass(TM) Clean Room Wall Pass-Through System; Ensures Room Isolation During Fluid Transfer
A United States patent has been awarded to AdvantaPass, a clean room wall pass-through system designed to transfer fluids between clean rooms during pharmaceutical and biopharmaceutical production. The system is the first of its kind to provide complete isolation between manufacturing suites when transferring multiple fluid lines through a single wall portal. AdvantaPass uses Single-Use components, such as tubing and seals, along with durable stainless steel in-wall parts. - November 20, 2014 - AdvantaPure
Available from MoBiTec GmbH: Unique Ready-to-Use Vectors for Live Cell Imaging of Nuclear Proteins
During cell division the kinetochore is the protein structure on chromatids where the spindle fibers attach to pull sister chromatids apart. MoBiTec now offers unique gene fusion constructs of proteins to investigate kinetochore formation and cell division. - November 20, 2014 - MoBiTec GmbH
Creative Diagnostics Announces Product Promotion for Antigens Towards the Worldwide Market
Creative Diagnostics - Quality monoclonal and polyclonal antibody provider for the global market at very substantial savings begins at this thanksgiving month. - November 19, 2014 - Creative Diagnostics
Experimentica Ltd Announces a Strategic Partnership with the Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland
Experimentica Ltd., a Finland-based ophthalmic CRO, announces a strategic partnership with The Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland. SILK is a research network composed of research units engaged in basic and clinical eye and vision research. Dr. Giedrius... - November 19, 2014 - Experimentica Ltd
Creative Bioarray’s High Quality Dry Bath Incubators
Creative Bioarray is a well-recognized biotech company. The company is specializing in providing bio-laboratory products and services such as human tissue, animal tissue, tissue array, microorganisms, cells, probes, cell services, biosample services, histology services, and also laboratory equipments. - November 16, 2014 - Creative Bioarray
Jake Worthington to Perform at Starry Night Houston
Houston native Jake Worthington, a recent finalist on The Voice, will perform at Starry Night Houston on Saturday, Nov. 15 at Discovery Green. The Pediatric Brain Tumor Foundation’s Starry Night 8.5K is an evening walk/run that shines a light on kids battling one of the deadliest forms of... - November 15, 2014 - Pediatric Brain Tumor Foundation
Atlanta, San Francisco Top $100,000 for Kids with Brain Tumors
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on children with brain tumors, attracted 875 participants in Atlanta and San Francisco on Nov. 8. At start time, the events had raised $116,000. The crowds came to the 8.5K events at Centennial Olympic Park... - November 15, 2014 - Pediatric Brain Tumor Foundation
MoBiTec GmbH, Germany, Offers New Bacillus Megaterium Strain for Gene Expression and Protein Production - YYBm1
MoBiTec GmbH expands its product line of tools for gene expression in Bacillus megaterium with the new expression host YYBm1. Strain YYBm1 is unable to utilize the expression system's inductor molecule xylose as carbon source. - November 13, 2014 - MoBiTec GmbH
MoBiTec GmbH's Supplier Peninsula Laboratories, USA, with New Corporate Website
Peninsula Laboratories International, Inc, USA, a leading supplier of superior immunology products, proudly announces its own corporate website www.penlabs.com. Formerly, PenLabs was integral part of Bachem's internet presence. - November 11, 2014 - MoBiTec GmbH
Creative Bioarray’s WISP-PTC Dry Bath Incubator
Creative Bioarray launches another brand new dry bath incubator: WISP-PTC Dry Bath Incubator, with the support of its advanced technology platform. - November 08, 2014 - Creative Bioarray
Creative Bioarray’s 3-in-I Mini Dry Bath Incubator
Creative Bioarray launches its 3-in-1 multifunctional Mini Dry Bath Incubator - WISP-TR Dry Bath Incubator. - November 06, 2014 - Creative Bioarray
Enzyme Activity Assay Service Are Available in Creative Biomart
Creative Biomart, a world leading supplier of recombinant proteins, antibodies, enzymes and other biotech services for the research community in the field of biology, has announced today for its official release of the novel service-- Enzyme activity assay. This assay is in the aim of assisting... - November 06, 2014 - Creative Biomart
Amoy Diagnostics, China, Expands List of CE-Marked Real-Time PCR Kits for Cancer Diagnostics
Amoy Diagnostics, who recently appointed MoBiTec GmbH as distributor for Germany, proudly announces the availability of further CE-marked detection kits, which are based on a proprietary real-time PCR technology called “ADx-ARMS,” for Cancer Diagnostics. - October 24, 2014 - MoBiTec GmbH
Boston, Philadelphia Join Starry Night to Cure the Kids
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on children with brain tumors, attracted more than 500 participants in Boston and Philadelphia on Oct. 18. At start time, the events had raised $61,000. The crowds came to the 8.5K events at Joe Moakley... - October 23, 2014 - Pediatric Brain Tumor Foundation
MoBiTec, Germany, and Amoy Diagnostics, China, Sign Distribution Agreement for the German Market
MoBiTec GmbH, Germany, focused on selling products for life science and IVD research, has entered into a distribution agreement with Amoy Diagnostics, China. Together with AmoyDx, MoBiTec will continue to expand its portfolio of premier brands. - October 19, 2014 - MoBiTec GmbH
Creative Diagnostics Releases the Hot Products of October for Monoclonal Antibodies
Creative Diagnostics announced the release of its hot products of Oct. 2014 for monoclonal antibodies. - October 17, 2014 - Creative Diagnostics
OutsourcePharma Advisory Board CRO Reviews Database Surpasses Growth Milestone
Online community of outsourcing decision makers doubles its CRO reviews database - October 15, 2014 - Life Science Strategy Group, LLC
Creative Biomart Newly Introduced It’s Fc Fusion Protein Production Service
Creative Biomart, a word leading Biotech Company had newly released its novel service of Fc Fusion Protein Production Service in the aim of providing more choices for the scientists conducting biomedical and immunology research. The potential clinical application of cytokins to modulate immune... - October 10, 2014 - Creative Biomart
Starry Night Chicago Raises Funds to Help Kids with Brain Tumors
Starry Night, the Pediatric Brain Tumor Foundation’s new walk/run that shines a light on childhood brain tumors, made its debut in Chicago on Oct. 4 with the support of more than 500 participants. At start time, the event had raised $46,000. The crowd came to the 8.5K at Arlington... - October 09, 2014 - Pediatric Brain Tumor Foundation
AveXis Announces the Completion of Dosing of the Low Dose Cohort in US Clinical Trial for Spinal Muscular Atrophy
AveXis, Inc., a clinic-stage gene therapy company, today announced the completion of dosing in the low dose cohort in the world's first human gene therapy trial for the treatment of infants with spinal muscular atrophy (SMA). The trial (NCT02122952) opened for enrollment in April... - October 08, 2014 - AveXis Inc.
AveXis Receives Orphan Drug Status from the US Food and Drug Administration (FDA) for chariSMA for the Treatment of Spinal Muscular Atrophy
AveXis Inc., a synthetic biology platform company primarily focused on developing treatments for Spinal Muscular Atrophy (SMA) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its product scAAV9, called chariSMA to treat Spinal Muscular Atrophy... - October 04, 2014 - AveXis Inc.
MoBiTec GmbH: PDE Inhibitors Show Sonic Effects on Prostate Cancer
In 2009, Phosphodiesterase 4D (PDE4D) was identified as a novel proliferation-promoting factor in prostate cancer. Now, the effects of two selective PDE4D inhibitors, NVP-ABE171 and cilomilast, as anti-prostate cancer therapies were examined. - October 02, 2014 - MoBiTec GmbH
Clinical Network Services (CNS) and Ventac Partners Sign Cooperative Partnership
Clinical Network Services (CNS) an integrated service consultancy focused on product development and Ventac Partners, a life science consulting firm, today announced that they have signed a cooperative partnership agreement to provide joint service offerings in the biotech and pharma sectors in fundraising, company evolution and drug development. The partnership pools the corporate expertise of Ventac Partners with the regulatory expertise of CNS and expands the geographical reach of both. - September 22, 2014 - Ventac Partners
Signed Robin Williams Skate Deck Part of Auction to Benefit PBTF
Actor and comedian Robin Williams was well-known for his philanthropy, especially for children’s causes. Just a few months before his death, he signed a skateboard to be included in an auction to help children with brain tumors. Williams worked with the skate deck’s artist, Cody Gallo,... - September 21, 2014 - Pediatric Brain Tumor Foundation